Saliva-based Screening Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Saliva-based Screening in Global, including the following market information:
Global Saliva-based Screening Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Saliva-based Screening market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Direct Sample to PCR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Saliva-based Screening include Thermo Fisher scientific, Qiagen, Hologic, Takara Bio Inc, Arcis Biotechnology Limited, GeneProof, Abacus ALS, Chai Inc. and Kolplast Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Saliva-based Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Saliva-based Screening Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Saliva-based Screening Market Segment Percentages, by Type, 2021 (%)
Global Saliva-based Screening Market Segment Percentages, by Application, 2021 (%)
Global Saliva-based Screening Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Saliva-based Screening revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Saliva-based Screening revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Saliva-based Screening Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Saliva-based Screening market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Direct Sample to PCR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Saliva-based Screening include Thermo Fisher scientific, Qiagen, Hologic, Takara Bio Inc, Arcis Biotechnology Limited, GeneProof, Abacus ALS, Chai Inc. and Kolplast Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Saliva-based Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Saliva-based Screening Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Saliva-based Screening Market Segment Percentages, by Type, 2021 (%)
- Direct Sample to PCR
- RT-qPCR
- Lateral Flow Assays
Global Saliva-based Screening Market Segment Percentages, by Application, 2021 (%)
- Diagnostic Laboratories
- Hospitals & Clinics
- Others
Global Saliva-based Screening Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Saliva-based Screening revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Saliva-based Screening revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Thermo Fisher scientific
- Qiagen
- Hologic
- Takara Bio Inc
- Arcis Biotechnology Limited
- GeneProof
- Abacus ALS
- Chai Inc.
- Kolplast Group
- Lucence Health INc
- Vitagene
- Therma Bright Inc
- ACON Laboratories, Inc
- TODA PHARMA
- Norgen Biotek Corp.
- Assure Tech. (Hangzhou) Co., Ltd
- Beijing Hotgen Biotech Co., Ltd
- Nantong Diagnos Biotechnology Co., Ltd
- NeuMoDx Molecular, Inc.
- KYODO INTERNATIONAL INC.
- Canvax
- Zymo Research Corporation.
- Salimetrics
- NEST Scientific USA
- Miraclean Technology Co. Ltd
- Mawi DNA Technologies
- Cell Projects Ltd.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Saliva-based Screening Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Saliva-based Screening Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL SALIVA-BASED SCREENING OVERALL MARKET SIZE
2.1 Global Saliva-based Screening Market Size: 2021 VS 2028
2.2 Global Saliva-based Screening Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Saliva-based Screening Players in Global Market
3.2 Top Global Saliva-based Screening Companies Ranked by Revenue
3.3 Global Saliva-based Screening Revenue by Companies
3.4 Top 3 and Top 5 Saliva-based Screening Companies in Global Market, by Revenue in 2021
3.5 Global Companies Saliva-based Screening Product Type
3.6 Tier 1, Tier 2 and Tier 3 Saliva-based Screening Players in Global Market
3.6.1 List of Global Tier 1 Saliva-based Screening Companies
3.6.2 List of Global Tier 2 and Tier 3 Saliva-based Screening Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Saliva-based Screening Market Size Markets, 2021 & 2028
4.1.2 Direct Sample to PCR
4.1.3 RT-qPCR
4.1.4 Lateral Flow Assays
4.2 By Type - Global Saliva-based Screening Revenue & Forecasts
4.2.1 By Type - Global Saliva-based Screening Revenue, 2017-2022
4.2.2 By Type - Global Saliva-based Screening Revenue, 2023-2028
4.2.3 By Type - Global Saliva-based Screening Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Saliva-based Screening Market Size, 2021 & 2028
5.1.2 Diagnostic Laboratories
5.1.3 Hospitals & Clinics
5.1.4 Others
5.2 By Application - Global Saliva-based Screening Revenue & Forecasts
5.2.1 By Application - Global Saliva-based Screening Revenue, 2017-2022
5.2.2 By Application - Global Saliva-based Screening Revenue, 2023-2028
5.2.3 By Application - Global Saliva-based Screening Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Saliva-based Screening Market Size, 2021 & 2028
6.2 By Region - Global Saliva-based Screening Revenue & Forecasts
6.2.1 By Region - Global Saliva-based Screening Revenue, 2017-2022
6.2.2 By Region - Global Saliva-based Screening Revenue, 2023-2028
6.2.3 By Region - Global Saliva-based Screening Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Saliva-based Screening Revenue, 2017-2028
6.3.2 US Saliva-based Screening Market Size, 2017-2028
6.3.3 Canada Saliva-based Screening Market Size, 2017-2028
6.3.4 Mexico Saliva-based Screening Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Saliva-based Screening Revenue, 2017-2028
6.4.2 Germany Saliva-based Screening Market Size, 2017-2028
6.4.3 France Saliva-based Screening Market Size, 2017-2028
6.4.4 U.K. Saliva-based Screening Market Size, 2017-2028
6.4.5 Italy Saliva-based Screening Market Size, 2017-2028
6.4.6 Russia Saliva-based Screening Market Size, 2017-2028
6.4.7 Nordic Countries Saliva-based Screening Market Size, 2017-2028
6.4.8 Benelux Saliva-based Screening Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Saliva-based Screening Revenue, 2017-2028
6.5.2 China Saliva-based Screening Market Size, 2017-2028
6.5.3 Japan Saliva-based Screening Market Size, 2017-2028
6.5.4 South Korea Saliva-based Screening Market Size, 2017-2028
6.5.5 Southeast Asia Saliva-based Screening Market Size, 2017-2028
6.5.6 India Saliva-based Screening Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Saliva-based Screening Revenue, 2017-2028
6.6.2 Brazil Saliva-based Screening Market Size, 2017-2028
6.6.3 Argentina Saliva-based Screening Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Saliva-based Screening Revenue, 2017-2028
6.7.2 Turkey Saliva-based Screening Market Size, 2017-2028
6.7.3 Israel Saliva-based Screening Market Size, 2017-2028
6.7.4 Saudi Arabia Saliva-based Screening Market Size, 2017-2028
6.7.5 UAE Saliva-based Screening Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Thermo Fisher scientific
7.1.1 Thermo Fisher scientific Corporate Summary
7.1.2 Thermo Fisher scientific Business Overview
7.1.3 Thermo Fisher scientific Saliva-based Screening Major Product Offerings
7.1.4 Thermo Fisher scientific Saliva-based Screening Revenue in Global Market (2017-2022)
7.1.5 Thermo Fisher scientific Key News
7.2 Qiagen
7.2.1 Qiagen Corporate Summary
7.2.2 Qiagen Business Overview
7.2.3 Qiagen Saliva-based Screening Major Product Offerings
7.2.4 Qiagen Saliva-based Screening Revenue in Global Market (2017-2022)
7.2.5 Qiagen Key News
7.3 Hologic
7.3.1 Hologic Corporate Summary
7.3.2 Hologic Business Overview
7.3.3 Hologic Saliva-based Screening Major Product Offerings
7.3.4 Hologic Saliva-based Screening Revenue in Global Market (2017-2022)
7.3.5 Hologic Key News
7.4 Takara Bio Inc
7.4.1 Takara Bio Inc Corporate Summary
7.4.2 Takara Bio Inc Business Overview
7.4.3 Takara Bio Inc Saliva-based Screening Major Product Offerings
7.4.4 Takara Bio Inc Saliva-based Screening Revenue in Global Market (2017-2022)
7.4.5 Takara Bio Inc Key News
7.5 Arcis Biotechnology Limited
7.5.1 Arcis Biotechnology Limited Corporate Summary
7.5.2 Arcis Biotechnology Limited Business Overview
7.5.3 Arcis Biotechnology Limited Saliva-based Screening Major Product Offerings
7.5.4 Arcis Biotechnology Limited Saliva-based Screening Revenue in Global Market (2017-2022)
7.5.5 Arcis Biotechnology Limited Key News
7.6 GeneProof
7.6.1 GeneProof Corporate Summary
7.6.2 GeneProof Business Overview
7.6.3 GeneProof Saliva-based Screening Major Product Offerings
7.6.4 GeneProof Saliva-based Screening Revenue in Global Market (2017-2022)
7.6.5 GeneProof Key News
7.7 Abacus ALS
7.7.1 Abacus ALS Corporate Summary
7.7.2 Abacus ALS Business Overview
7.7.3 Abacus ALS Saliva-based Screening Major Product Offerings
7.7.4 Abacus ALS Saliva-based Screening Revenue in Global Market (2017-2022)
7.7.5 Abacus ALS Key News
7.8 Chai Inc.
7.8.1 Chai Inc. Corporate Summary
7.8.2 Chai Inc. Business Overview
7.8.3 Chai Inc. Saliva-based Screening Major Product Offerings
7.8.4 Chai Inc. Saliva-based Screening Revenue in Global Market (2017-2022)
7.8.5 Chai Inc. Key News
7.9 Kolplast Group
7.9.1 Kolplast Group Corporate Summary
7.9.2 Kolplast Group Business Overview
7.9.3 Kolplast Group Saliva-based Screening Major Product Offerings
7.9.4 Kolplast Group Saliva-based Screening Revenue in Global Market (2017-2022)
7.9.5 Kolplast Group Key News
7.10 Lucence Health INc
7.10.1 Lucence Health INc Corporate Summary
7.10.2 Lucence Health INc Business Overview
7.10.3 Lucence Health INc Saliva-based Screening Major Product Offerings
7.10.4 Lucence Health INc Saliva-based Screening Revenue in Global Market (2017-2022)
7.10.5 Lucence Health INc Key News
7.11 Vitagene
7.11.1 Vitagene Corporate Summary
7.11.2 Vitagene Business Overview
7.11.3 Vitagene Saliva-based Screening Major Product Offerings
7.11.4 Vitagene Saliva-based Screening Revenue in Global Market (2017-2022)
7.11.5 Vitagene Key News
7.12 Therma Bright Inc
7.12.1 Therma Bright Inc Corporate Summary
7.12.2 Therma Bright Inc Business Overview
7.12.3 Therma Bright Inc Saliva-based Screening Major Product Offerings
7.12.4 Therma Bright Inc Saliva-based Screening Revenue in Global Market (2017-2022)
7.12.5 Therma Bright Inc Key News
7.13 ACON Laboratories, Inc
7.13.1 ACON Laboratories, Inc Corporate Summary
7.13.2 ACON Laboratories, Inc Business Overview
7.13.3 ACON Laboratories, Inc Saliva-based Screening Major Product Offerings
7.13.4 ACON Laboratories, Inc Saliva-based Screening Revenue in Global Market (2017-2022)
7.13.5 ACON Laboratories, Inc Key News
7.14 TODA PHARMA
7.14.1 TODA PHARMA Corporate Summary
7.14.2 TODA PHARMA Business Overview
7.14.3 TODA PHARMA Saliva-based Screening Major Product Offerings
7.14.4 TODA PHARMA Saliva-based Screening Revenue in Global Market (2017-2022)
7.14.5 TODA PHARMA Key News
7.15 Norgen Biotek Corp.
7.15.1 Norgen Biotek Corp. Corporate Summary
7.15.2 Norgen Biotek Corp. Business Overview
7.15.3 Norgen Biotek Corp. Saliva-based Screening Major Product Offerings
7.15.4 Norgen Biotek Corp. Saliva-based Screening Revenue in Global Market (2017-2022)
7.15.5 Norgen Biotek Corp. Key News
7.16 Assure Tech. (Hangzhou) Co., Ltd
7.16.1 Assure Tech. (Hangzhou) Co., Ltd Corporate Summary
7.16.2 Assure Tech. (Hangzhou) Co., Ltd Business Overview
7.16.3 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Major Product Offerings
7.16.4 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Revenue in Global Market (2017-2022)
7.16.5 Assure Tech. (Hangzhou) Co., Ltd Key News
7.17 Beijing Hotgen Biotech Co., Ltd
7.17.1 Beijing Hotgen Biotech Co., Ltd Corporate Summary
7.17.2 Beijing Hotgen Biotech Co., Ltd Business Overview
7.17.3 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Major Product Offerings
7.17.4 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Revenue in Global Market (2017-2022)
7.17.5 Beijing Hotgen Biotech Co., Ltd Key News
7.18 Nantong Diagnos Biotechnology Co., Ltd
7.18.1 Nantong Diagnos Biotechnology Co., Ltd Corporate Summary
7.18.2 Nantong Diagnos Biotechnology Co., Ltd Business Overview
7.18.3 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Major Product Offerings
7.18.4 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Revenue in Global Market (2017-2022)
7.18.5 Nantong Diagnos Biotechnology Co., Ltd Key News
7.19 NeuMoDx Molecular, Inc.
7.19.1 NeuMoDx Molecular, Inc. Corporate Summary
7.19.2 NeuMoDx Molecular, Inc. Business Overview
7.19.3 NeuMoDx Molecular, Inc. Saliva-based Screening Major Product Offerings
7.19.4 NeuMoDx Molecular, Inc. Saliva-based Screening Revenue in Global Market (2017-2022)
7.19.5 NeuMoDx Molecular, Inc. Key News
7.20 KYODO INTERNATIONAL INC.
7.20.1 KYODO INTERNATIONAL INC. Corporate Summary
7.20.2 KYODO INTERNATIONAL INC. Business Overview
7.20.3 KYODO INTERNATIONAL INC. Saliva-based Screening Major Product Offerings
7.20.4 KYODO INTERNATIONAL INC. Saliva-based Screening Revenue in Global Market (2017-2022)
7.20.5 KYODO INTERNATIONAL INC. Key News
7.21 Canvax
7.21.1 Canvax Corporate Summary
7.21.2 Canvax Business Overview
7.21.3 Canvax Saliva-based Screening Major Product Offerings
7.21.4 Canvax Saliva-based Screening Revenue in Global Market (2017-2022)
7.21.5 Canvax Key News
7.22 Zymo Research Corporation.
7.22.1 Zymo Research Corporation. Corporate Summary
7.22.2 Zymo Research Corporation. Business Overview
7.22.3 Zymo Research Corporation. Saliva-based Screening Major Product Offerings
7.22.4 Zymo Research Corporation. Saliva-based Screening Revenue in Global Market (2017-2022)
7.22.5 Zymo Research Corporation. Key News
7.23 Salimetrics
7.23.1 Salimetrics Corporate Summary
7.23.2 Salimetrics Business Overview
7.23.3 Salimetrics Saliva-based Screening Major Product Offerings
7.23.4 Salimetrics Saliva-based Screening Revenue in Global Market (2017-2022)
7.23.5 Salimetrics Key News
7.24 NEST Scientific USA
7.24.1 NEST Scientific USA Corporate Summary
7.24.2 NEST Scientific USA Business Overview
7.24.3 NEST Scientific USA Saliva-based Screening Major Product Offerings
7.24.4 NEST Scientific USA Saliva-based Screening Revenue in Global Market (2017-2022)
7.24.5 NEST Scientific USA Key News
7.25 Miraclean Technology Co. Ltd
7.25.1 Miraclean Technology Co. Ltd Corporate Summary
7.25.2 Miraclean Technology Co. Ltd Business Overview
7.25.3 Miraclean Technology Co. Ltd Saliva-based Screening Major Product Offerings
7.25.4 Miraclean Technology Co. Ltd Saliva-based Screening Revenue in Global Market (2017-2022)
7.25.5 Miraclean Technology Co. Ltd Key News
7.26 Mawi DNA Technologies
7.26.1 Mawi DNA Technologies Corporate Summary
7.26.2 Mawi DNA Technologies Business Overview
7.26.3 Mawi DNA Technologies Saliva-based Screening Major Product Offerings
7.26.4 Mawi DNA Technologies Saliva-based Screening Revenue in Global Market (2017-2022)
7.26.5 Mawi DNA Technologies Key News
7.27 Cell Projects Ltd.
7.27.1 Cell Projects Ltd. Corporate Summary
7.27.2 Cell Projects Ltd. Business Overview
7.27.3 Cell Projects Ltd. Saliva-based Screening Major Product Offerings
7.27.4 Cell Projects Ltd. Saliva-based Screening Revenue in Global Market (2017-2022)
7.27.5 Cell Projects Ltd. Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Saliva-based Screening Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Saliva-based Screening Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL SALIVA-BASED SCREENING OVERALL MARKET SIZE
2.1 Global Saliva-based Screening Market Size: 2021 VS 2028
2.2 Global Saliva-based Screening Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Saliva-based Screening Players in Global Market
3.2 Top Global Saliva-based Screening Companies Ranked by Revenue
3.3 Global Saliva-based Screening Revenue by Companies
3.4 Top 3 and Top 5 Saliva-based Screening Companies in Global Market, by Revenue in 2021
3.5 Global Companies Saliva-based Screening Product Type
3.6 Tier 1, Tier 2 and Tier 3 Saliva-based Screening Players in Global Market
3.6.1 List of Global Tier 1 Saliva-based Screening Companies
3.6.2 List of Global Tier 2 and Tier 3 Saliva-based Screening Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Saliva-based Screening Market Size Markets, 2021 & 2028
4.1.2 Direct Sample to PCR
4.1.3 RT-qPCR
4.1.4 Lateral Flow Assays
4.2 By Type - Global Saliva-based Screening Revenue & Forecasts
4.2.1 By Type - Global Saliva-based Screening Revenue, 2017-2022
4.2.2 By Type - Global Saliva-based Screening Revenue, 2023-2028
4.2.3 By Type - Global Saliva-based Screening Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Saliva-based Screening Market Size, 2021 & 2028
5.1.2 Diagnostic Laboratories
5.1.3 Hospitals & Clinics
5.1.4 Others
5.2 By Application - Global Saliva-based Screening Revenue & Forecasts
5.2.1 By Application - Global Saliva-based Screening Revenue, 2017-2022
5.2.2 By Application - Global Saliva-based Screening Revenue, 2023-2028
5.2.3 By Application - Global Saliva-based Screening Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Saliva-based Screening Market Size, 2021 & 2028
6.2 By Region - Global Saliva-based Screening Revenue & Forecasts
6.2.1 By Region - Global Saliva-based Screening Revenue, 2017-2022
6.2.2 By Region - Global Saliva-based Screening Revenue, 2023-2028
6.2.3 By Region - Global Saliva-based Screening Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Saliva-based Screening Revenue, 2017-2028
6.3.2 US Saliva-based Screening Market Size, 2017-2028
6.3.3 Canada Saliva-based Screening Market Size, 2017-2028
6.3.4 Mexico Saliva-based Screening Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Saliva-based Screening Revenue, 2017-2028
6.4.2 Germany Saliva-based Screening Market Size, 2017-2028
6.4.3 France Saliva-based Screening Market Size, 2017-2028
6.4.4 U.K. Saliva-based Screening Market Size, 2017-2028
6.4.5 Italy Saliva-based Screening Market Size, 2017-2028
6.4.6 Russia Saliva-based Screening Market Size, 2017-2028
6.4.7 Nordic Countries Saliva-based Screening Market Size, 2017-2028
6.4.8 Benelux Saliva-based Screening Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Saliva-based Screening Revenue, 2017-2028
6.5.2 China Saliva-based Screening Market Size, 2017-2028
6.5.3 Japan Saliva-based Screening Market Size, 2017-2028
6.5.4 South Korea Saliva-based Screening Market Size, 2017-2028
6.5.5 Southeast Asia Saliva-based Screening Market Size, 2017-2028
6.5.6 India Saliva-based Screening Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Saliva-based Screening Revenue, 2017-2028
6.6.2 Brazil Saliva-based Screening Market Size, 2017-2028
6.6.3 Argentina Saliva-based Screening Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Saliva-based Screening Revenue, 2017-2028
6.7.2 Turkey Saliva-based Screening Market Size, 2017-2028
6.7.3 Israel Saliva-based Screening Market Size, 2017-2028
6.7.4 Saudi Arabia Saliva-based Screening Market Size, 2017-2028
6.7.5 UAE Saliva-based Screening Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Thermo Fisher scientific
7.1.1 Thermo Fisher scientific Corporate Summary
7.1.2 Thermo Fisher scientific Business Overview
7.1.3 Thermo Fisher scientific Saliva-based Screening Major Product Offerings
7.1.4 Thermo Fisher scientific Saliva-based Screening Revenue in Global Market (2017-2022)
7.1.5 Thermo Fisher scientific Key News
7.2 Qiagen
7.2.1 Qiagen Corporate Summary
7.2.2 Qiagen Business Overview
7.2.3 Qiagen Saliva-based Screening Major Product Offerings
7.2.4 Qiagen Saliva-based Screening Revenue in Global Market (2017-2022)
7.2.5 Qiagen Key News
7.3 Hologic
7.3.1 Hologic Corporate Summary
7.3.2 Hologic Business Overview
7.3.3 Hologic Saliva-based Screening Major Product Offerings
7.3.4 Hologic Saliva-based Screening Revenue in Global Market (2017-2022)
7.3.5 Hologic Key News
7.4 Takara Bio Inc
7.4.1 Takara Bio Inc Corporate Summary
7.4.2 Takara Bio Inc Business Overview
7.4.3 Takara Bio Inc Saliva-based Screening Major Product Offerings
7.4.4 Takara Bio Inc Saliva-based Screening Revenue in Global Market (2017-2022)
7.4.5 Takara Bio Inc Key News
7.5 Arcis Biotechnology Limited
7.5.1 Arcis Biotechnology Limited Corporate Summary
7.5.2 Arcis Biotechnology Limited Business Overview
7.5.3 Arcis Biotechnology Limited Saliva-based Screening Major Product Offerings
7.5.4 Arcis Biotechnology Limited Saliva-based Screening Revenue in Global Market (2017-2022)
7.5.5 Arcis Biotechnology Limited Key News
7.6 GeneProof
7.6.1 GeneProof Corporate Summary
7.6.2 GeneProof Business Overview
7.6.3 GeneProof Saliva-based Screening Major Product Offerings
7.6.4 GeneProof Saliva-based Screening Revenue in Global Market (2017-2022)
7.6.5 GeneProof Key News
7.7 Abacus ALS
7.7.1 Abacus ALS Corporate Summary
7.7.2 Abacus ALS Business Overview
7.7.3 Abacus ALS Saliva-based Screening Major Product Offerings
7.7.4 Abacus ALS Saliva-based Screening Revenue in Global Market (2017-2022)
7.7.5 Abacus ALS Key News
7.8 Chai Inc.
7.8.1 Chai Inc. Corporate Summary
7.8.2 Chai Inc. Business Overview
7.8.3 Chai Inc. Saliva-based Screening Major Product Offerings
7.8.4 Chai Inc. Saliva-based Screening Revenue in Global Market (2017-2022)
7.8.5 Chai Inc. Key News
7.9 Kolplast Group
7.9.1 Kolplast Group Corporate Summary
7.9.2 Kolplast Group Business Overview
7.9.3 Kolplast Group Saliva-based Screening Major Product Offerings
7.9.4 Kolplast Group Saliva-based Screening Revenue in Global Market (2017-2022)
7.9.5 Kolplast Group Key News
7.10 Lucence Health INc
7.10.1 Lucence Health INc Corporate Summary
7.10.2 Lucence Health INc Business Overview
7.10.3 Lucence Health INc Saliva-based Screening Major Product Offerings
7.10.4 Lucence Health INc Saliva-based Screening Revenue in Global Market (2017-2022)
7.10.5 Lucence Health INc Key News
7.11 Vitagene
7.11.1 Vitagene Corporate Summary
7.11.2 Vitagene Business Overview
7.11.3 Vitagene Saliva-based Screening Major Product Offerings
7.11.4 Vitagene Saliva-based Screening Revenue in Global Market (2017-2022)
7.11.5 Vitagene Key News
7.12 Therma Bright Inc
7.12.1 Therma Bright Inc Corporate Summary
7.12.2 Therma Bright Inc Business Overview
7.12.3 Therma Bright Inc Saliva-based Screening Major Product Offerings
7.12.4 Therma Bright Inc Saliva-based Screening Revenue in Global Market (2017-2022)
7.12.5 Therma Bright Inc Key News
7.13 ACON Laboratories, Inc
7.13.1 ACON Laboratories, Inc Corporate Summary
7.13.2 ACON Laboratories, Inc Business Overview
7.13.3 ACON Laboratories, Inc Saliva-based Screening Major Product Offerings
7.13.4 ACON Laboratories, Inc Saliva-based Screening Revenue in Global Market (2017-2022)
7.13.5 ACON Laboratories, Inc Key News
7.14 TODA PHARMA
7.14.1 TODA PHARMA Corporate Summary
7.14.2 TODA PHARMA Business Overview
7.14.3 TODA PHARMA Saliva-based Screening Major Product Offerings
7.14.4 TODA PHARMA Saliva-based Screening Revenue in Global Market (2017-2022)
7.14.5 TODA PHARMA Key News
7.15 Norgen Biotek Corp.
7.15.1 Norgen Biotek Corp. Corporate Summary
7.15.2 Norgen Biotek Corp. Business Overview
7.15.3 Norgen Biotek Corp. Saliva-based Screening Major Product Offerings
7.15.4 Norgen Biotek Corp. Saliva-based Screening Revenue in Global Market (2017-2022)
7.15.5 Norgen Biotek Corp. Key News
7.16 Assure Tech. (Hangzhou) Co., Ltd
7.16.1 Assure Tech. (Hangzhou) Co., Ltd Corporate Summary
7.16.2 Assure Tech. (Hangzhou) Co., Ltd Business Overview
7.16.3 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Major Product Offerings
7.16.4 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Revenue in Global Market (2017-2022)
7.16.5 Assure Tech. (Hangzhou) Co., Ltd Key News
7.17 Beijing Hotgen Biotech Co., Ltd
7.17.1 Beijing Hotgen Biotech Co., Ltd Corporate Summary
7.17.2 Beijing Hotgen Biotech Co., Ltd Business Overview
7.17.3 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Major Product Offerings
7.17.4 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Revenue in Global Market (2017-2022)
7.17.5 Beijing Hotgen Biotech Co., Ltd Key News
7.18 Nantong Diagnos Biotechnology Co., Ltd
7.18.1 Nantong Diagnos Biotechnology Co., Ltd Corporate Summary
7.18.2 Nantong Diagnos Biotechnology Co., Ltd Business Overview
7.18.3 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Major Product Offerings
7.18.4 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Revenue in Global Market (2017-2022)
7.18.5 Nantong Diagnos Biotechnology Co., Ltd Key News
7.19 NeuMoDx Molecular, Inc.
7.19.1 NeuMoDx Molecular, Inc. Corporate Summary
7.19.2 NeuMoDx Molecular, Inc. Business Overview
7.19.3 NeuMoDx Molecular, Inc. Saliva-based Screening Major Product Offerings
7.19.4 NeuMoDx Molecular, Inc. Saliva-based Screening Revenue in Global Market (2017-2022)
7.19.5 NeuMoDx Molecular, Inc. Key News
7.20 KYODO INTERNATIONAL INC.
7.20.1 KYODO INTERNATIONAL INC. Corporate Summary
7.20.2 KYODO INTERNATIONAL INC. Business Overview
7.20.3 KYODO INTERNATIONAL INC. Saliva-based Screening Major Product Offerings
7.20.4 KYODO INTERNATIONAL INC. Saliva-based Screening Revenue in Global Market (2017-2022)
7.20.5 KYODO INTERNATIONAL INC. Key News
7.21 Canvax
7.21.1 Canvax Corporate Summary
7.21.2 Canvax Business Overview
7.21.3 Canvax Saliva-based Screening Major Product Offerings
7.21.4 Canvax Saliva-based Screening Revenue in Global Market (2017-2022)
7.21.5 Canvax Key News
7.22 Zymo Research Corporation.
7.22.1 Zymo Research Corporation. Corporate Summary
7.22.2 Zymo Research Corporation. Business Overview
7.22.3 Zymo Research Corporation. Saliva-based Screening Major Product Offerings
7.22.4 Zymo Research Corporation. Saliva-based Screening Revenue in Global Market (2017-2022)
7.22.5 Zymo Research Corporation. Key News
7.23 Salimetrics
7.23.1 Salimetrics Corporate Summary
7.23.2 Salimetrics Business Overview
7.23.3 Salimetrics Saliva-based Screening Major Product Offerings
7.23.4 Salimetrics Saliva-based Screening Revenue in Global Market (2017-2022)
7.23.5 Salimetrics Key News
7.24 NEST Scientific USA
7.24.1 NEST Scientific USA Corporate Summary
7.24.2 NEST Scientific USA Business Overview
7.24.3 NEST Scientific USA Saliva-based Screening Major Product Offerings
7.24.4 NEST Scientific USA Saliva-based Screening Revenue in Global Market (2017-2022)
7.24.5 NEST Scientific USA Key News
7.25 Miraclean Technology Co. Ltd
7.25.1 Miraclean Technology Co. Ltd Corporate Summary
7.25.2 Miraclean Technology Co. Ltd Business Overview
7.25.3 Miraclean Technology Co. Ltd Saliva-based Screening Major Product Offerings
7.25.4 Miraclean Technology Co. Ltd Saliva-based Screening Revenue in Global Market (2017-2022)
7.25.5 Miraclean Technology Co. Ltd Key News
7.26 Mawi DNA Technologies
7.26.1 Mawi DNA Technologies Corporate Summary
7.26.2 Mawi DNA Technologies Business Overview
7.26.3 Mawi DNA Technologies Saliva-based Screening Major Product Offerings
7.26.4 Mawi DNA Technologies Saliva-based Screening Revenue in Global Market (2017-2022)
7.26.5 Mawi DNA Technologies Key News
7.27 Cell Projects Ltd.
7.27.1 Cell Projects Ltd. Corporate Summary
7.27.2 Cell Projects Ltd. Business Overview
7.27.3 Cell Projects Ltd. Saliva-based Screening Major Product Offerings
7.27.4 Cell Projects Ltd. Saliva-based Screening Revenue in Global Market (2017-2022)
7.27.5 Cell Projects Ltd. Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Saliva-based Screening Market Opportunities & Trends in Global Market
Table 2. Saliva-based Screening Market Drivers in Global Market
Table 3. Saliva-based Screening Market Restraints in Global Market
Table 4. Key Players of Saliva-based Screening in Global Market
Table 5. Top Saliva-based Screening Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Saliva-based Screening Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Saliva-based Screening Revenue Share by Companies, 2017-2022
Table 8. Global Companies Saliva-based Screening Product Type
Table 9. List of Global Tier 1 Saliva-based Screening Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Saliva-based Screening Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Saliva-based Screening Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Saliva-based Screening Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Saliva-based Screening Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Saliva-based Screening Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Saliva-based Screening Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Saliva-based Screening Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Saliva-based Screening Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Saliva-based Screening Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Saliva-based Screening Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Saliva-based Screening Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Saliva-based Screening Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Saliva-based Screening Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Saliva-based Screening Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Saliva-based Screening Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Saliva-based Screening Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Saliva-based Screening Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Saliva-based Screening Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Saliva-based Screening Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Saliva-based Screening Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher scientific Corporate Summary
Table 31. Thermo Fisher scientific Saliva-based Screening Product Offerings
Table 32. Thermo Fisher scientific Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 33. Qiagen Corporate Summary
Table 34. Qiagen Saliva-based Screening Product Offerings
Table 35. Qiagen Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 36. Hologic Corporate Summary
Table 37. Hologic Saliva-based Screening Product Offerings
Table 38. Hologic Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 39. Takara Bio Inc Corporate Summary
Table 40. Takara Bio Inc Saliva-based Screening Product Offerings
Table 41. Takara Bio Inc Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 42. Arcis Biotechnology Limited Corporate Summary
Table 43. Arcis Biotechnology Limited Saliva-based Screening Product Offerings
Table 44. Arcis Biotechnology Limited Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 45. GeneProof Corporate Summary
Table 46. GeneProof Saliva-based Screening Product Offerings
Table 47. GeneProof Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 48. Abacus ALS Corporate Summary
Table 49. Abacus ALS Saliva-based Screening Product Offerings
Table 50. Abacus ALS Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 51. Chai Inc. Corporate Summary
Table 52. Chai Inc. Saliva-based Screening Product Offerings
Table 53. Chai Inc. Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 54. Kolplast Group Corporate Summary
Table 55. Kolplast Group Saliva-based Screening Product Offerings
Table 56. Kolplast Group Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 57. Lucence Health INc Corporate Summary
Table 58. Lucence Health INc Saliva-based Screening Product Offerings
Table 59. Lucence Health INc Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 60. Vitagene Corporate Summary
Table 61. Vitagene Saliva-based Screening Product Offerings
Table 62. Vitagene Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 63. Therma Bright Inc Corporate Summary
Table 64. Therma Bright Inc Saliva-based Screening Product Offerings
Table 65. Therma Bright Inc Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 66. ACON Laboratories, Inc Corporate Summary
Table 67. ACON Laboratories, Inc Saliva-based Screening Product Offerings
Table 68. ACON Laboratories, Inc Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 69. TODA PHARMA Corporate Summary
Table 70. TODA PHARMA Saliva-based Screening Product Offerings
Table 71. TODA PHARMA Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 72. Norgen Biotek Corp. Corporate Summary
Table 73. Norgen Biotek Corp. Saliva-based Screening Product Offerings
Table 74. Norgen Biotek Corp. Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 75. Assure Tech. (Hangzhou) Co., Ltd Corporate Summary
Table 76. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product Offerings
Table 77. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 78. Beijing Hotgen Biotech Co., Ltd Corporate Summary
Table 79. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product Offerings
Table 80. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 81. Nantong Diagnos Biotechnology Co., Ltd Corporate Summary
Table 82. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product Offerings
Table 83. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 84. NeuMoDx Molecular, Inc. Corporate Summary
Table 85. NeuMoDx Molecular, Inc. Saliva-based Screening Product Offerings
Table 86. NeuMoDx Molecular, Inc. Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 87. KYODO INTERNATIONAL INC. Corporate Summary
Table 88. KYODO INTERNATIONAL INC. Saliva-based Screening Product Offerings
Table 89. KYODO INTERNATIONAL INC. Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 90. Canvax Corporate Summary
Table 91. Canvax Saliva-based Screening Product Offerings
Table 92. Canvax Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 93. Zymo Research Corporation. Corporate Summary
Table 94. Zymo Research Corporation. Saliva-based Screening Product Offerings
Table 95. Zymo Research Corporation. Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 96. Salimetrics Corporate Summary
Table 97. Salimetrics Saliva-based Screening Product Offerings
Table 98. Salimetrics Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 99. NEST Scientific USA Corporate Summary
Table 100. NEST Scientific USA Saliva-based Screening Product Offerings
Table 101. NEST Scientific USA Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 102. Miraclean Technology Co. Ltd Corporate Summary
Table 103. Miraclean Technology Co. Ltd Saliva-based Screening Product Offerings
Table 104. Miraclean Technology Co. Ltd Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 105. Mawi DNA Technologies Corporate Summary
Table 106. Mawi DNA Technologies Saliva-based Screening Product Offerings
Table 107. Mawi DNA Technologies Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 108. Cell Projects Ltd. Corporate Summary
Table 109. Cell Projects Ltd. Saliva-based Screening Product Offerings
Table 110. Cell Projects Ltd. Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 1. Saliva-based Screening Market Opportunities & Trends in Global Market
Table 2. Saliva-based Screening Market Drivers in Global Market
Table 3. Saliva-based Screening Market Restraints in Global Market
Table 4. Key Players of Saliva-based Screening in Global Market
Table 5. Top Saliva-based Screening Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Saliva-based Screening Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Saliva-based Screening Revenue Share by Companies, 2017-2022
Table 8. Global Companies Saliva-based Screening Product Type
Table 9. List of Global Tier 1 Saliva-based Screening Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Saliva-based Screening Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Saliva-based Screening Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Saliva-based Screening Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Saliva-based Screening Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Saliva-based Screening Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Saliva-based Screening Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Saliva-based Screening Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Saliva-based Screening Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Saliva-based Screening Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Saliva-based Screening Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Saliva-based Screening Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Saliva-based Screening Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Saliva-based Screening Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Saliva-based Screening Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Saliva-based Screening Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Saliva-based Screening Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Saliva-based Screening Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Saliva-based Screening Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Saliva-based Screening Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Saliva-based Screening Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher scientific Corporate Summary
Table 31. Thermo Fisher scientific Saliva-based Screening Product Offerings
Table 32. Thermo Fisher scientific Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 33. Qiagen Corporate Summary
Table 34. Qiagen Saliva-based Screening Product Offerings
Table 35. Qiagen Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 36. Hologic Corporate Summary
Table 37. Hologic Saliva-based Screening Product Offerings
Table 38. Hologic Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 39. Takara Bio Inc Corporate Summary
Table 40. Takara Bio Inc Saliva-based Screening Product Offerings
Table 41. Takara Bio Inc Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 42. Arcis Biotechnology Limited Corporate Summary
Table 43. Arcis Biotechnology Limited Saliva-based Screening Product Offerings
Table 44. Arcis Biotechnology Limited Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 45. GeneProof Corporate Summary
Table 46. GeneProof Saliva-based Screening Product Offerings
Table 47. GeneProof Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 48. Abacus ALS Corporate Summary
Table 49. Abacus ALS Saliva-based Screening Product Offerings
Table 50. Abacus ALS Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 51. Chai Inc. Corporate Summary
Table 52. Chai Inc. Saliva-based Screening Product Offerings
Table 53. Chai Inc. Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 54. Kolplast Group Corporate Summary
Table 55. Kolplast Group Saliva-based Screening Product Offerings
Table 56. Kolplast Group Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 57. Lucence Health INc Corporate Summary
Table 58. Lucence Health INc Saliva-based Screening Product Offerings
Table 59. Lucence Health INc Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 60. Vitagene Corporate Summary
Table 61. Vitagene Saliva-based Screening Product Offerings
Table 62. Vitagene Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 63. Therma Bright Inc Corporate Summary
Table 64. Therma Bright Inc Saliva-based Screening Product Offerings
Table 65. Therma Bright Inc Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 66. ACON Laboratories, Inc Corporate Summary
Table 67. ACON Laboratories, Inc Saliva-based Screening Product Offerings
Table 68. ACON Laboratories, Inc Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 69. TODA PHARMA Corporate Summary
Table 70. TODA PHARMA Saliva-based Screening Product Offerings
Table 71. TODA PHARMA Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 72. Norgen Biotek Corp. Corporate Summary
Table 73. Norgen Biotek Corp. Saliva-based Screening Product Offerings
Table 74. Norgen Biotek Corp. Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 75. Assure Tech. (Hangzhou) Co., Ltd Corporate Summary
Table 76. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product Offerings
Table 77. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 78. Beijing Hotgen Biotech Co., Ltd Corporate Summary
Table 79. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product Offerings
Table 80. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 81. Nantong Diagnos Biotechnology Co., Ltd Corporate Summary
Table 82. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product Offerings
Table 83. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 84. NeuMoDx Molecular, Inc. Corporate Summary
Table 85. NeuMoDx Molecular, Inc. Saliva-based Screening Product Offerings
Table 86. NeuMoDx Molecular, Inc. Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 87. KYODO INTERNATIONAL INC. Corporate Summary
Table 88. KYODO INTERNATIONAL INC. Saliva-based Screening Product Offerings
Table 89. KYODO INTERNATIONAL INC. Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 90. Canvax Corporate Summary
Table 91. Canvax Saliva-based Screening Product Offerings
Table 92. Canvax Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 93. Zymo Research Corporation. Corporate Summary
Table 94. Zymo Research Corporation. Saliva-based Screening Product Offerings
Table 95. Zymo Research Corporation. Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 96. Salimetrics Corporate Summary
Table 97. Salimetrics Saliva-based Screening Product Offerings
Table 98. Salimetrics Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 99. NEST Scientific USA Corporate Summary
Table 100. NEST Scientific USA Saliva-based Screening Product Offerings
Table 101. NEST Scientific USA Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 102. Miraclean Technology Co. Ltd Corporate Summary
Table 103. Miraclean Technology Co. Ltd Saliva-based Screening Product Offerings
Table 104. Miraclean Technology Co. Ltd Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 105. Mawi DNA Technologies Corporate Summary
Table 106. Mawi DNA Technologies Saliva-based Screening Product Offerings
Table 107. Mawi DNA Technologies Saliva-based Screening Revenue (US$, Mn), (2017-2022)
Table 108. Cell Projects Ltd. Corporate Summary
Table 109. Cell Projects Ltd. Saliva-based Screening Product Offerings
Table 110. Cell Projects Ltd. Saliva-based Screening Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Saliva-based Screening Segment by Type in 2021
Figure 2. Saliva-based Screening Segment by Application in 2021
Figure 3. Global Saliva-based Screening Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Saliva-based Screening Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Saliva-based Screening Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Saliva-based Screening Revenue in 2021
Figure 8. By Type - Global Saliva-based Screening Revenue Market Share, 2017-2028
Figure 9. By Application - Global Saliva-based Screening Revenue Market Share, 2017-2028
Figure 10. By Region - Global Saliva-based Screening Revenue Market Share, 2017-2028
Figure 11. By Country - North America Saliva-based Screening Revenue Market Share, 2017-2028
Figure 12. US Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Saliva-based Screening Revenue Market Share, 2017-2028
Figure 16. Germany Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 17. France Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Saliva-based Screening Revenue Market Share, 2017-2028
Figure 24. China Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 28. India Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Saliva-based Screening Revenue Market Share, 2017-2028
Figure 30. Brazil Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Saliva-based Screening Revenue Market Share, 2017-2028
Figure 33. Turkey Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher scientific Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Qiagen Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Hologic Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Takara Bio Inc Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Arcis Biotechnology Limited Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GeneProof Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Abacus ALS Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Chai Inc. Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Kolplast Group Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Lucence Health INc Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Vitagene Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Therma Bright Inc Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. ACON Laboratories, Inc Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. TODA PHARMA Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Norgen Biotek Corp. Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. NeuMoDx Molecular, Inc. Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. KYODO INTERNATIONAL INC. Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Canvax Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Zymo Research Corporation. Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Salimetrics Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. NEST Scientific USA Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. Miraclean Technology Co. Ltd Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 62. Mawi DNA Technologies Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 63. Cell Projects Ltd. Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Saliva-based Screening Segment by Type in 2021
Figure 2. Saliva-based Screening Segment by Application in 2021
Figure 3. Global Saliva-based Screening Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Saliva-based Screening Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Saliva-based Screening Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Saliva-based Screening Revenue in 2021
Figure 8. By Type - Global Saliva-based Screening Revenue Market Share, 2017-2028
Figure 9. By Application - Global Saliva-based Screening Revenue Market Share, 2017-2028
Figure 10. By Region - Global Saliva-based Screening Revenue Market Share, 2017-2028
Figure 11. By Country - North America Saliva-based Screening Revenue Market Share, 2017-2028
Figure 12. US Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Saliva-based Screening Revenue Market Share, 2017-2028
Figure 16. Germany Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 17. France Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Saliva-based Screening Revenue Market Share, 2017-2028
Figure 24. China Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 28. India Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Saliva-based Screening Revenue Market Share, 2017-2028
Figure 30. Brazil Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Saliva-based Screening Revenue Market Share, 2017-2028
Figure 33. Turkey Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Saliva-based Screening Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher scientific Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Qiagen Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Hologic Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Takara Bio Inc Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Arcis Biotechnology Limited Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GeneProof Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Abacus ALS Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Chai Inc. Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Kolplast Group Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Lucence Health INc Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Vitagene Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Therma Bright Inc Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. ACON Laboratories, Inc Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. TODA PHARMA Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Norgen Biotek Corp. Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. NeuMoDx Molecular, Inc. Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. KYODO INTERNATIONAL INC. Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Canvax Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Zymo Research Corporation. Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Salimetrics Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. NEST Scientific USA Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. Miraclean Technology Co. Ltd Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 62. Mawi DNA Technologies Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 63. Cell Projects Ltd. Saliva-based Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
